22 73

Cited 7 times in

Re-irradiation of recurrent esophageal cancer after primary definitive radiotherapy

Authors
 Kim Young Suk ; Lee Chang Geol ; Koom Woong Sub ; Cho Yona ; Lee Joohwan ; Kim Taehyung ; Kim Kyung Hwan 
Citation
 Radiation Oncology Journal, Vol.30(4) : 182~188, 2012 
Journal Title
 Radiation Oncology Journal 
ISSN
 2234-1900 
Issue Date
2012
Abstract
Purpose: For recurrent esophageal cancer after primary definitive radiotherapy, no general treatment guidelines are available. We evaluated the toxicities and clinical outcomes of re-irradiation (re-RT) for recurrent esophageal cancer. Materials and Methods: We analyzed 10 patients with recurrent esophageal cancer treated with re-RT after primary definitive radiotherapy. The median time interval between primary radiotherapy and re-RT was 15.6 months (range, 4.8 to 36.4 months). The total dose of primary radiotherapy was a median of 50.4 Gy (range, 50.4 to 63.0 Gy). The total dose of re-RT was a median of 46.5 Gy (range, 44.0 to 50.4 Gy). Results: The median follow-up period was 4.9 months (range, 2.6 to 11.4 months). The tumor response at 3 months after the end of re-RT was complete response (n = 2), partial response (n = 1), stable disease (n = 2), and progressive disease (n = 5). Grade 5 tracheoesophageal fistula developed in three patients. The time interval between primary radiotherapy and re-RT was less than 12 months in two of these three patients. Late toxicities included grade 1 dysphagia (n = 1). Conclusion: Re-RT of recurrent esophageal cancer after primary radiotherapy can cause severe toxicity.
URI
http://ir.ymlib.yonsei.ac.kr/handle/22282913/91776
DOI
10.3857/roj.2012.30.4.182
Appears in Collections:
1. 연구논문 > 1. College of Medicine > Dept. of Radiation Oncology
Yonsei Authors
사서에게 알리기
  feedback
Files in This Item:
T201205611.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse